JACQUELINE JONES: Open Payments
NPI 1396868618 · ROCHESTER, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$759 in 40 payments from 14 companies in 2025. Trend: 2023 $1,229 · 2024 $952 · 2025 $759
Food & beverage: $759
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $273 |
| Amgen Inc. | 8 | $186 |
| E.R. Squibb & Sons, L.L.C. | 3 | $58 |
| Alnylam Pharmaceuticals Inc. | 2 | $36 |
| PFIZER INC. | 2 | $32 |
| Actelion Pharmaceuticals US, Inc. | 1 | $29 |
| SCPHARMACEUTICALS INC. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Chiesi USA, Inc. | 1 | $20 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $17 |
Products named: LEQVIO, REPATHA, CAMZYOS, VYNDAQEL, OPSUMIT, FUROSCIX, AREXVY, KENGREAL.
Industry payments across MI — which companies pay providers there.
